Further downstream, integrins can activate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) in pancreatic cancer [23,68], but not in ovarian cancer [34]. This evidence concerns the gene NFKB1 and ovarian carcinoma.